Not that I'm holding my breath for CETP inhibitors but the cited 4% reduction in MI risk was calculated from the association between MI and SNPs and observed in genetic variant (modelled allele) near the CETP gene. CETP inhibitors might have a stronger effect on LDL (and on MI risk) than the predicted genetic variant plus they also reduce triglycerides and perhaps have an effect on ApoA-I, lpLPA2 and such.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.